loss of JAK1/2 and interferon-γ (IFN-γ) receptor expression), or tumor-extrinsic factors including promoting expression of immunosuppressive cytokines or metabolites, recruitment of immunosuppressive cells (ex. This evidence concerns the gene IFNG and neoplasm.